Mycobacterium Citations List: February 2023

Literature Citations

1. Propitious Indazole Compounds as beta-Ketoacyl-ACP Synthase Inhibitors and Mechanisms Unfolded for TB Cure: Integrated Rational Design and Md Simulations. Adewumi, A.T., W.M. Oluyemi, Y.A. Adekunle, N. Adewumi, M.I. Alahmdi, M.E.S. Soliman, and N.E. Abo-Dya. ChemistrySelect, 2023. 8(3): e202203877. ISI[000913808000001].
[WOS]. TB_02_2023.

2. Identification of 2-Amino benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis. Bonnett, S., J.A. Jee, S. Chettiar, Y. Ovechkina, A. Korkegian, E. Greve, J. Odingo, and T. Parish. Microbiology Spectrum, 2023. 11(1): e0497422. PMID[36688635]. PMCID[PMC9927457].
[PubMed]. TB_02_2023.

3. Bolaamphiphile Analogues of 12-bis-THA Cl(2) Are Potent Antimicrobial Therapeutics with Distinct Mechanisms of Action against Bacterial, Mycobacterial, and Fungal Pathogens. Di Blasio, S., M. Clarke, C.K. Hind, M. Asai, L. Laurence, A. Benvenuti, M. Hassan, D. Semenya, D.K. Man, V. Horrocks, G. Manzo, S. Van Der Lith, C. Lam, E. Gentile, C. Annette, J. Bosse, Y. Li, B. Panaretou, P.R. Langford, B.D. Robertson, J.K.W. Lam, J.M. Sutton, M. McArthur, and A.J. Mason. mSphere, 2023. 8(1): e0050822. PMID[36511707]. PMCID[PMC9942557].
[PubMed]. TB_02_2023.

4. New Tetrahydropyrimidine-1,2,3-triazole Clubbed Compounds: Antitubercular Activity and Thymidine Monophosphate Kinase (TMPKmt) Inhibition. El-Shoukrofy, M.S., A. Atta, S. Fahmy, D. Sriram, M.A. Mahran, and I.M. Labouta. Bioorganic Chemistry, 2023. 131: 106312. PMID[36528922].
[PubMed]. TB_02_2023.

5. 2-[(2-Amino-6-methylpyrimidin-4-yl)sulfanyl]-N-arylacetamides: Discovery of a New Class of Anti-tubercular Agents and Prospects for Their Further Structural Modification. Erkin, A.V., E.B. Serebryakov, and V.I. Krutikov. Bioorganic & Medicinal Chemistry Letters, 2023. 83: 129189. PMID[36805047].
[PubMed]. TB_02_2023.

6. Structure Activity Relationship of Pyrazinoic acid Analogs as Potential Antimycobacterial Agents. Hegde, P.V., W.W. Aragaw, M.S. Cole, G. Jachak, P. Ragunathan, S. Sharma, A. Harikishore, G. Gruber, T. Dick, and C.C. Aldrich. Bioorganic & Medicinal Chemistry, 2022. 74: 117046. PMID[36228522].
[PubMed]. TB_02_2023.

7. Artemisia afra and Artemisia annua Extracts Have Bactericidal Activity against Mycobacterium tuberculosis in Physiologically Relevant Carbon Sources and Hypoxia. Kiani, B.H., M.N. Alonso, P.J. Weathers, and S.S. Shell. Pathogens, 2023. 12(2): 227. PMID[36839499]. PMCID[PMC9963027].
[PubMed]. TB_02_2023.

8. Design, Synthesis, and Antimycobacterial Evaluation of Novel Tetrahydroisoquinoline hydrazide Analogs. Kumar, B.V.S., Y.M. Khetmalis, A. Nandikolla, B.K. Kumar, K. Van Calster, S. Murugesan, D. Cappoen, and K. Sekhar. Chemistry & Biodiversity, 2023. 20(2): e202200939. PMID[36597269].
[PubMed]. TB_02_2023.

9. Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against Mycobacterium tuberculosis. Li, C., X. Tian, Z. Huang, X. Gou, B. Yusuf, C. Li, Y. Gao, S. Liu, Y. Wang, T. Yang, Z. Liu, Q. Sun, T. Zhang, and Y. Luo. Journal of Medicinal Chemistry, 2023. 66(4): p. 2699-2716. PMID[36735271].
[PubMed]. TB_02_2023.

10. Efficacy of Replacing Linezolid with OTB-658 in Anti-tuberculosis Regimens in Murine Models. Liu, H., H. Zhu, L. Fu, W. Zhang, X. Chen, B. Wang, S. Guo, Y. Ding, N. Wang, D. Li, and Y. Lu. Antimicrobial Agents and Chemotherapy, 2023. 67(2): e0139922. PMID[36622240]. PMCID[PMC9933650].
[PubMed]. TB_02_2023.

11. In Silico and in Vitro Evaluation of a New N'-(2-Arylacetyl)-4-(1H-pyrrol-1-yl)benzohydrazides as Potential Antimicrobial Agents. Mahnashi, M.H., B. Kittur, S.R.P. Kumar, A.S. Alqahtani, A. Al Ali, M.A. Alshahrani, I.A. Shaikh, and S.D. Joshi. Indian Journal of Heterocyclic Chemistry, 2022. 32(4): p. 523-530. ISI[000911427900017].
[WOS]. TB_02_2023.

12. Synthesis, Crystal Structure, Electronic Structure, and Anti-tubercular Properties of Two New Coumarin Derivatives Bearing Theophylline Moiety. Managutti, P.B., S.N. Mangasuli, and S.S. Malaganvi. Journal of Molecular Structure, 2023. 1277: 134888. ISI[000923463200001].
[WOS]. TB_02_2023.

13. Essential Oil of Gallesia integrifolia Is Active against Mycobacteria. Montaholi, D.C., T.L. Valverde, E.G. Sampiron, W.C. Bortoluci, Z.C. Gazim, K.R. Caleffi-Ferracioli, R.B.L. Scodro, V.L.D. Siqueira, and R.F. Cardoso. Future Microbiology. 18: p. 107-116. PMID[36661097].
[PubMed]. TB_02_2023.

14. Repurposing β-Lactams for the Treatment of Mycobacterium kansasii Infections: An in Vitro Study. Muñoz-Muñoz, L., J.A. Aínsa, and S. Ramón-García. Antibiotics, 2023. 12(2): 335. PMID[36830246]. PMCID[PMC9952313].
[PubMed]. TB_02_2023.

15. Activity of Oral Tebipenem-Avibactam in a Mouse Model of Mycobacterium abscessus Lung Infection. Negatu, D.A., R. González Del Río, M. Cacho-Izquierdo, D. Barros-Aguirre, J. Lelievre, J. Rullas, P. Casado, U.S. Ganapathy, M.D. Zimmerman, M. Gengenbacher, V. Dartois, and T. Dick. Antimicrobial Agents and Chemotherapy, 2023. 67(2): e0145922. PMID[36688684]. PMCID[PMC9933631].
[PubMed]. TB_02_2023.

16. In Vitro, in Vivo and in Silico Assessment of the Antimicrobial and Immunomodulatory Effects of a Water Buffalo Cathelicidin (WBCATH) in Experimental Pulmonary Tuberculosis. Palacios, J.B., J. Barrios-Payan, D. Mata-Espinosa, J.V. Lara-Espinosa, J.C. Leon-Contreras, G.H. Lushington, T. Melgarejo, and R. Hernandez-Pando. Antibiotics, 2023. 12(1): 75. PMID[36671276]. PMCID[PMC9855185].
[PubMed]. TB_02_2023.

17. Conjugates of Chloramphenicol Amine and Berberine as Antimicrobial Agents. Pavlova, J.A., A.G. Tereshchenkov, P.A. Nazarov, D.A. Lukianov, D.A. Skvortsov, V.I. Polshakov, B.F. Vasilieva, O.V. Efremenkova, M.Y. Kaiumov, A. Paleskava, A.L. Konevega, O.A. Dontsova, I.A. Osterman, A.A. Bogdanov, and N.V. Sumbatyan. Antibiotics, 2023. 12(1): 15. PMID[36671216]. PMCID[PMC9854996].
[PubMed]. TB_02_2023.

18. Design, Synthesis and anti-TB and Anti-bacterial Activity of Ciprofloxacin Derivatives Containing N-(Amino)piperazine Moieties. Qin, X.Y., B. Jiang, H.J. Song, N. Du, Y.H. Zhang, X.J. Zhong, J.Z. Wu, T.Z. Xue, M.L. Liu, A.P. Wang, S.L. Wang, and K. Lv. Medicinal Chemistry Research. 32: p. 556-570. ISI[000921874800001].
[WOS]. TB_02_2023.

19. The Chemistry of Vernonanthura nudiflora (Less.) H. Rob. Flowers and Its Antimicrobial Activities. Ramos, A.V.G., N. de Sá, D.L.O. Araújo, M.R.P. Cabral, G.F. Costacurta, B.C. de Freitas, L.V. Vilegas, R.B.L. Scodro, V.L.D. Siqueira, E.S.K. Cotica, M.R.B. do Carmo, M.H. Sarragiotto, and D.C. Baldoqui. Natural Product Research, 2023. 37(3): p. 502-507. PMID[34558351].
[PubMed]. TB_02_2023.

20. Synthesis of Novel 5-Oxo-1,2,4-oxadiazole Derivatives as Antitubercular Agents and Their Molecular Docking Study toward Enoyl Reductase (InhA) Enzyme. Reddy, B.R.S., K.S. Babu, N. Mulakayala, and V.P.R. Gajulapalli. ChemistrySelect, 2023. 8(4): e202204093. ISI[000918502100001].
[WOS]. TB_02_2023.

21. Identification and Characterization of Three New Antimicrobial Peptides from the Marine Mollusk Nerita versicolor (Gmelin, 1791). Rodriguez, A., E.M. Martell-Huguet, M. González-García, D. Alpízar-Pedraza, A. Alba, A.A. Vazquez, M. Grieshober, B. Spellerberg, S. Stenger, J. Münch, A.K. Kissmann, F. Rosenau, L.A. Wessjohann, S. Wiese, L. Ständker, and A.J. Otero-Gonzalez. International Journal of Molecular Sciences, 2023. 24(4): 3852. PMID[36835264]. PMCID[PMC9968088].
[PubMed]. TB_02_2023.

22. One-pot Sonochemical Synthesis and in Silico/ in Vitro Antitubercular Evaluation of 1-Methyl-3-propyl-1H-pyrazole Containing Polynuclear Fused N -Heteroarenes. Sangepu, V.R., K.K. Jain, R.D. Bhoomireddy, D. Sharma, R. Venkateshwarlu, R. Kapavarapu, R. Dandela, and M. Pal. Journal of Molecular Structure, 2023. 1278: 134909. ISI[000923172000001].
[WOS]. TB_02_2023.

23. Discovery of Oxazoline-triazole Based Hybrid Molecules as DNA Gyrase Inhibitors: A New Class of Potential Anti-Tubercular Agents. Shinde, S.R., S.N. Inamdar, M. Shinde, C. Pawar, B. Kushwaha, V.A. Obakachi, A. Kajee, R. Chauhan, and R. Karpoormath. Journal of Molecular Structure, 2023. 1273: 134243. ISI[000911581500002].
[WOS]. TB_02_2023.

24. Design, Synthesis and Antimicrobial Evaluation of New N-(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(hetero)aryl-2-carboxamides as Potential Inhibitors of Mycobacterial Leucyl-tRNA Synthetase. Šlechta, P., A.A. Needle, O. Jand'ourek, P. Paterová, K. Konečná, P. Bárta, J. Kuneš, V. Kubíček, M. Doležal, and M. Kučerová-Chlupáčová. International Journal of Molecular Sciences, 2023. 24(3): 2951. PMID[36769275]. PMCID[PMC9917560].
[PubMed]. TB_02_2023.

25. Dithiocarbamates and Dithiocarbonates Containing 6-Nitrosaccharin Scaffold: Synthesis, Antimycobacterial Activity and in Silico Target Prediction Using Ensemble Docking-based Reverse Virtual Screening. Trawally, M., K. Demir-Yazici, S.I. Dingis-Birgnl, K. Kaya, A. Akdemir, and O. Guzel-Akdemir. Journal of Molecular Structure, 2023. 1277: 134818. ISI[000913728700001].
[WOS]. TB_02_2023.

26. QSAR Studies, Molecular Docking, Molecular Dynamics, Synthesis, and Biological Evaluation of Novel Quinolinone-based Thiosemicarbazones against Mycobacterium tuberculosis. Valencia, J., V. Rubio, G. Puerto, L. Vasquez, A. Bernal, J.R. Mora, S.A. Cuesta, J.L. Paz, B. Insuasty, R. Abonia, J. Quiroga, A. Insuasty, A. Coneo, O. Vidal, E. Marquez, and D. Insuasty. Antibiotics, 2023. 12(1): 61. PMID[36671262]. PMCID[PMC9854539].
[PubMed]. TB_02_2023.

27. The Synergetic Effect of Sitafloxacin-Arbekacin Combination in the Mycobacterium abscessus Species. Watanabe, J., H. Ihara, S. Takei, A. Nakamura, Y. Fujimoto, T. Handoh, K. Kurokawa, Y. Arai, K. Shibayama, I. Sumiyoshi, Y. Ochi, T. Okabe, S. Misawa, S. Togo, T. Naito, Y. Tabe, T. Miida, and K. Takahashi. Scientific Reports, 2023. 13(1): 2027. PMID[36739345]. PMCID[PMC9899205].
[PubMed]. TB_02_2023.

28. Discovery of Natural-product-derived Sequanamycins as Potent Oral Anti-tuberculosis Agents. Zhang, J., C. Lair, C. Roubert, K. Amaning, M.B. Barrio, Y. Benedetti, Z. Cui, Z. Xing, X. Li, S.G. Franzblau, N. Baurin, F. Bordon-Pallier, C. Cantalloube, S. Sans, S. Silve, I. Blanc, L. Fraisse, A. Rak, L.B. Jenner, G. Yusupova, M. Yusupov, J. Zhang, T. Kaneko, T.J. Yang, N. Fotouhi, E. Nuermberger, S. Tyagi, F. Betoudji, A. Upton, J.C. Sacchettini, and S. Lagrange. Cell, 2023. 186(5): p. 1013-1025.e1024. PMID[36827973]. PMCID[PMC9994261].
[PubMed]. TB_02_2023.

29. In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria. Zhang, T., J. Du, L. Dong, F. Wang, L. Zhao, J. Jia, C. Wang, M. Cheng, X. Yu, and H. Huang. Microbiology Spectrum, 2023. 11(1): e0323822. PMID[36475850]. PMCID[PMC9927410].
[PubMed]. TB_02_2023.

30. Antimycobacterial Compound of Cynoglossum lanceolatum Forsk.: Bioassay Guided Isolation, Molecular Docking, Synthesis of Analogs, and a Plausible Mechanism of Action. Zhao, X., L. Wang, M.Y. Xia, and Z.C. Yang. Chemistry & Biodiversity, 2023. 20(2): e202200965. PMID[36567254].
[PubMed]. TB_02_2023.

Patent Citations

31. Oxadiazole Derivatives as Tuberculosis Inhibitors and Their Preparation. Pardal Filipe, A.E., C.P. Da Costa Pereira Rosa, A.V. Cordeiro Simoes, J.C. Ramos Damil, J.P. Silva Serra, A.L. Almeida Ferreira, R.I. Gomes Neves, and S.A. Marques Homem e Sousa dos Santos. Patent. 2023. WO2022-IB55995 2023275744: 94 pp.
[Patent]. TB_02_2023.